A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The main goal of this trial is to learn more about the safety and tolerability of Lu AG09222 when taken together with ubrogepant. This includes looking for any new or worsening medical issues the participants have with the treatment. During the trial, participants with migraine will receive ubrogepant oral tablets and an injection of either Lu AG09222 or a placebo.
Epistemonikos ID: fc6f821d4b8eae4e7fc57e17c1f2cc23ce672831
First added on: Sep 01, 2024